Slim Pharmaceuticals appoints Riza Cassim as CEO

SLIM Pharmaceuticals Ltd., has announced the appointment of Riza Cassim as its new Chief Executive Officer.

- 

With over three decades of experience across multinational pharmaceutical giants, Cassim brings a wealth of expertise, a proven track record of leadership, and a clear vision for the future of Slim Pharmaceuticals.

Founded in 2011, Slim Pharmaceuticals has steadily emerged as a trusted name in the pharmaceutical sector, offering a diverse portfolio that spans generic medicines, biologics, biosimilars, nutraceuticals, surgical instruments, diagnostics, and cosmeceuticals. The company has built longstanding partnerships with over 35 globally renowned manufacturers, including Roche, Baxter, and Otsuka, while serving more than 2,500 hospitals and pharmacies across Sri Lanka through a robust islandwide distribution network. Its guiding mission has been clear from inception: to combine international quality with accessibility and affordability, thereby transforming wellness for every Sri Lankan.